Articles On Medadvisor (ASX:MDR)

ASX healthcare sector gains 1.99% in November while benchmark ASX 200 down 2.66% Mach7 rises 50% in November with health imaging stock outlining a growth strategy at its AGM  Island Pharmaceuticals rises after FDA confirms Galidesivir will...

Highlights MedAdvisor’s price-to-sales ratio lags the industry Revenue has declined relative to peers Future growth forecasts remain below sector expectations MedAdvisor Limited (ASX:MDR) has low revenue growth and a modest P/S ra...

Integral Diagnostics and Medadvisor have new CEOs after the latest round of changes at the top Mayne’s refrain: let the Takeovers Panel decide It’s a case of the MEGnificent Five as Compumedics sells another brain-scanning device in China...

ASX healthcare sector fell 4.83% in October and is down more than 19% YTD CSL shares fall more than 15% on October 28 after management trims FY26 guidance Nyrada surges 165% in October on board changes and progress in phase 2a trial    Wi...

Optiscan Imaging led the biotech pack in October, while some of the Big Four stocks were late scratchings Does CSL have an iron deficiency? Weebit Nano ‘mini me’ Dorsavi quietly jockeys for position in the high-stakes chip race   The ASX...

ASX slides 13 points, down 0.15pc Energy gives up early gains, still positive as oil climbs 5pc Healthcare leads losses ASX closes week pretty much flat It’s been a defensive week for the ASX 200, coming off a hot gold rally and a record...

While sector conditions are improving, investors still can pick up marked-down, revenue-generating biotechs Dozens of offshore life science plays trade at below net asset backing, but the discounts on the ASX aren’t quite so harsh Investor...

The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on sector CSL had its biggest ever one day fall on August 19, down 17% following softer FY25 results and restructure plans Despite the broader...

Perversely, Polynovo stands to benefit from a US reimbursement cut for outpatients ASX biotechs had a poor August, but they will Spring into action Race Oncology opens Hong Kong site in “cautious” trial rollout   PolyNovo (ASX:PNV) shares...

Australia’s S&P/ASX 200 rose 3.10% in August and has posted gains of 12.33% so far for CY25 Materials led the gainers up 9.19%, while Healthcare fell 13.21% with CSL having its biggest ever daily fall Rare earths explorer Kaili Resourc...

The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum  Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of Febri...

 Plenty of biotechs are lodging late in the piece, but without too many ‘dog ate my homework’ excuses Telehealth group looks to post-pandemic recovery   Botanix, Amplia and Vitrafy pass muster with the brokers   Some students hand in thei...

ASX crescendos, adding 0.9pc to close at new all-time high of 8639 points Powerful gains across every sector, with all 11 closing higher Financials leads wins, with major banks at the vanguard A fanfare of triumphs The ASX was singing tod...

It was a tale of two halves for the ASX today, and neither were great  Caution abounds ahead of two major market-moving events this week, including RBA and Trump decisions Utilities stock Origin Energy was a big-cap MVP today, although the...

ASX hits the breaks, adding just 0.08pc Info tech also contracted, adding 0.54pc compared to more than 1pc earlier in the session Profit taking drives materials, banks lower   3pm slump has ASX yawning to close The ASX 200 pulled back fro...

ASX health up 1.6% over five days as Morgans’ Scott Power says the mood is positive for start of FY26 Wound management house Tetratherix make its ASX debut and breaks an IPO drought for sector ProMedicus surges past $300 for first time fol...

The ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6.64% Morgans healthcare analyst Iain Wilkie said June likely saw some tax loss selling before EOFY  Amplia up 300% in June after complete re...

Resources stocks surge; materials sector up 3.02pc ASX 200 Banks fall, shedding 1.3% as finance loses 1.27pc Vietnam inks trade deal with US one week ahead of tariff-pause deadline   ASX wobbles to the finish The ASX 200 was keeping us gu...

ASX ends day on new record high at 8597 points 10 of 11 sectors higher with broad strength across market Materials leads gains, up 1.38pc   ASX almost breaks through 8600-point ceiling The ASX 200 had one of its best trading days in month...

As today’s Medadvisor deal attests, underperforming biotech assets are getting a bite or two Next Science shares continue to rally, but the company is still valued at less than Demant’s offer price for most of its assets Neurizon enters a...

Bioxyne stars with a 720% gain in the 2024-25 year Paradigm shares soar 34% after $41 million convertible note deal Biotechs turn to debt funding The ASX biotech sector’s best EOFY performer has come from left field: the local and Europ...

US health secretary sacks 17-member panel that advises on US vaccine policy, to “re-establish public confidence in vaccine science” FDA delivers Argenica a stroke trial knock-back, but Syntara is in the fast lane EZZ Life Science soars up...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

ASX lifts 0.48pc as attention turns to US-China trade talks Info Tech leads gains, up 1.83pc with All Tech Index climbing 1.36pc Materials lags behind, slipping 0.46pc   The ASX was significantly less squirrely today, seeming to gain conf...

Highlights ASX200 shows positive movement, with the Energy sector leading Companies such as CTI Logistics (CLX), Accent Group (AX1), and EZZ Life Science Holdings (EZZ) feature among low-price stocks AMCIL (AMH), LGI Limited...

Highlights Energy and uranium stocks supported market strength amid global trade discussions ASX 200 rose alongside the ASX Small Ords and ASX 200 Resources indices Standout moves from TMX, MDR, ZIP, KLS and multiple uranium...

Highlights ASX 200 advanced as energy stocks rebounded, supported by movement in global crude benchmarks Boss Energy, Ampol, and Santos were among the notable gainers in the energy segment Zip climbed after reaffirming perfo...

US Secretary of the Treasury Scott Bessent is expected to meet with senior Chinese officials on Thursday Oil price hike lifts Energy sector more than 2pc Healthcare weighs on market under tariff shadow, down more than 1pc   The ASX has bu...

Medadvisor shares soar up to 60% after the company flags the sale of its Australian business Pot stock Althea sees better fortunes in the THC-infused beverage sector Clinuvel’s phase III vitiligo trial is fully recruited   With operation...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks off in earnes...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

ASX drops heavily as Trump’s tariffs spark chaos Energy stocks hit hard Breville and Ansell scramble to neutralise tariffs   The ASX copped another big drop on Friday, tumbling 2.44% as global markets went into freefall. For the week, the...

The guillotines are swooshing at the FDA as a reported 3500 staff get the chop French to say ‘oui’ to fully legal medicinal cannabis Bell Potter values Opthea at 5 cents per share   Grisly tales are emerging from the corridors of the US F...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

Two ASX gambling shares are making some big moves today on the heels of some big announcements. One of the ASX shares is taking a tumble on the news, while the other is soaring higher on Thursday. For some context, the All Ordinaries IndexÂ...

PointsBet Holdings Ltd (ASX: PBH) shares are taking off on Wednesday morning. At the time of writing, the ASX tech stock is up 34% to $1.11. This follows news that the sports betting company has accepted a takeover offer. ASX tech stock jum...

The Origin Energy Ltd (ASX: ORG) share price is leaping higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) energy provider closed yesterday trading for $10.26. In morning trade on Thursday, shares are changing hands for $10.47...

  Emyria says its ‘real world’ MDMA trial shows a “sustained improvement” in post-traumatic stress disorder (PTSD) symptoms Argenica says its traumatic brain injury candidate works in rats – and ferrets The biotech sector advanced to recor...

The S&P/ASX 200 Index (ASX: XJO) is having a very poor start to the week. In afternoon trade, the benchmark index is down 1.7% to 8,388.5 points. Four ASX shares that are falling more than most today are listed below. Here's why they a...

The S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a high. At the time of writing, the benchmark index is up 0.75% to 8,556.6 points. Four ASX shares that have failed to follow the market higher today are listed below. He...

According to the Australian Bureau of Statistics, the average age of retirement in Australia is on the up. But how much superannuation is enough to fund your retirement? Of the 4.2 million retirees in Australia in 2022-23, the average ag...

Origin Energy Ltd (ASX: ORG) shares are on the move on Friday. In morning trade, the energy retailer's shares are down 3.5% to $10.82. This follows the release of its quarterly update from the three months ended 31 December 2024.. Origin En...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

ASX hits three-month low as Fed dampens rate cut hopes ASX CHESS system is down Mesoblast shares reverse some of yesterday’s 50pc gain   It’s been a rough week for Aussie shares, with the ASX 200 slumping to a three-month low on Friday. T...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

ASX health stocks fall 1.3% in past five days, while broader market is marginally up 0.7%  Neuren soars on sale of priority review voucher and $50 million share buyback Neurizon releases positive preclinical results on lead drug candidate...

ASX up, Xero leads gains Miners hit as iron ore drops, Variscan jumps 50pc Asian stocks down, Bitcoin hits US$93k before retreating   Aussie shares climbed higher on Thursday, powered by a rally in tech companies and the big banks. At the...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

The S&P/ASX 200 fell 1.3% in October with small cap companies outperforming S&P Dow Jones Indices said financials led the gains in October and is up 30% YTD Ovanti rose 525% in October after appointment of former Zip US CFO Simon K...

ASX opens November lower, led by financial sector sell-off Macquarie Group fell after profit decline Ironbark Zinc jumps 75% on new leadership   The ASX kicked off November with a thud, sliding about 0.5%. This  follows a tough session o...